Pharmacokinetic Modelling of Efavirenz, Atazanavir, Lamivudine and Tenofovir in the Female Genital Tract of HIV-Infected Pre-Menopausal Women
Julie B. Dumond(University of North Carolina at Chapel Hill), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Myron S. Cohen(University of North Carolina at Chapel Hill), Alan Forrest(University of North Carolina at Chapel Hill), Racheal Kendrick(University of North Carolina at Chapel Hill), Samira M. Garonzik(New York University), Kristine B. Patterson(University of North Carolina at Chapel Hill), Melanie R. Nicol(University of Minnesota)
Cited by 26
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557